GENE ONLINE|News &
Opinion
Blog

Asia-Pacific
Allergic Asthma
LEO Pharma Strikes Deal with Asian Firms to Develop Atopic Dermatitis & Allergic Asthma Drug
2020-04-17
Trials & Approvals Anti-PD-1
Beigene’s Tislelizumab-Chemo Combo Nails Primary Endpoint in Phase 3 Trial
2020-04-16
Asia-Pacific Alpha Helices
Eisai Obtains Novel Anti-Cancer Molecules via PRISM BioLab Contract
2020-04-13
COVID-19 Japan
Chugai Initiates Actemra’s Phase 3 COVID-19 Trials in Japan
2020-04-11
Anti-cancer
Samsung Biologics Inks CDO Contract with PharmAbcine to Develop Novel Drug
2020-04-08
COVID-19
Weekly Cover：Updates on COVID-19 in Asia
2020-04-08
Rare Disease
Daiichi Sankyo Invests in Ultragenyx’s Technology to Bolster Gene Therapy Pipeline
2020-04-02
Cancer
Amgen to Serve Japanese Healthcare Market with Complete Ownership of 7 Year Joint Venture
2020-04-01
Daiichi Sankyo Seeks Yescarta Approval in Japan for Relapsed or Refractory B-cell Lymphoma
2020-04-01
COVID-19 Japan
Japan Trials Asthma Drug Alvesco to fight COVID-19
2020-03-29
R&D Rare Disease
Mochida Pharma, Gene Techno Science Collaborate to Develop Regenerative Medicine for Rare Disease
2020-03-28
Trials & Approvals
Green Cross Cell Seeks FDA approval for CAR-T therapy against pancreatic cancer
2020-03-27
R&D
Weekly Cover: Eisai to Launch “NouKNOWTM” in Japan for Regular Self-assessment of Brain Health
2020-03-26
Trials & Approvals Lung Cancer
Japan Approves World’s First Therapy for Metastatic Non–Small Cell Lung Cancer with METex14
2020-03-26
COVID-19
Pharma Firm AnGes and Osaka University to Initiate Coronavirus Vaccine Testing on Animals
2020-03-25
1 … 26 27 28 29 30 … 35
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top